Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07418775
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Questionnaire — BEHAVIORAL
    A questionnaire will be administered in person or online
  • Medical Record Review — OTHER
    Medical records will be reviewed for study specific data collection

Study Details

Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.

Key Dates

Start date
Jan 16, 2026
Status verified
May 2026
Primary completion
Jan 1, 2031
Completion
Jan 1, 2032

Study Design

Enrollment
3,000 participants (estimated)

Arms

  • Arm: Participants with Meningioma
    Adult patients who have been diagnosed with a meningioma will be asked to complete a one-time survey, which will take roughly 20 minutes to complete. Participants will also have medical records reviewed to capture additional data relating to the participants medical history.

Primary Outcome Measure

Identifying potential social and structural determinants of health (SSDH) [ Time Frame: Up to 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94143
Zora Arum
[email protected]
877-827-3222
[email protected]
877-827-3222
David Raleigh, MD PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By condition
Brain cancer
By specialty
OncologyNeuro-oncology
By research site
University of California San Francisco· San Francisco, CA

Related Studies